↓ Skip to main content

Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid‐refractory ulcerative colitis: A retrospective observational study

Overview of attention for article published in Inflammatory Bowel Diseases, March 2011
Altmetric Badge

Mentioned by

patent
2 patents

Citations

dimensions_citation
54 Dimensions

Readers on

mendeley
68 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid‐refractory ulcerative colitis: A retrospective observational study
Published in
Inflammatory Bowel Diseases, March 2011
DOI 10.1002/ibd.21680
Pubmed ID
Authors

Mats Sjöberg, Andrea Walch, Mina Meshkat, Anders Gustavsson, Gunnar Järnerot, Harald Vogelsang, Erik Hertervig, Gottfried Novacek, Ingalill Friis‐Liby, Lars Blomquist, Sieglinde Angelberger, Per Karlen, Christer Grännö, Mogens Vilien, Magnus Ström, Hans Verbaan, Per M. Hellström, Clemens Dejaco, Anders Magnuson, Jonas Halfvarson, Walter Reinisch, Curt Tysk

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 68 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 3%
United Kingdom 1 1%
Czechia 1 1%
Unknown 64 94%

Demographic breakdown

Readers by professional status Count As %
Researcher 10 15%
Other 8 12%
Student > Postgraduate 7 10%
Student > Master 6 9%
Student > Ph. D. Student 5 7%
Other 20 29%
Unknown 12 18%
Readers by discipline Count As %
Medicine and Dentistry 44 65%
Agricultural and Biological Sciences 3 4%
Computer Science 2 3%
Pharmacology, Toxicology and Pharmaceutical Science 1 1%
Economics, Econometrics and Finance 1 1%
Other 5 7%
Unknown 12 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 October 2017.
All research outputs
#8,534,528
of 25,373,627 outputs
Outputs from Inflammatory Bowel Diseases
#1,752
of 3,731 outputs
Outputs of similar age
#43,865
of 119,017 outputs
Outputs of similar age from Inflammatory Bowel Diseases
#16
of 37 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,731 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one is in the 41st percentile – i.e., 41% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 119,017 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 37 others from the same source and published within six weeks on either side of this one. This one is in the 29th percentile – i.e., 29% of its contemporaries scored the same or lower than it.